Research

The Centre for Pathogen Genomics at the University of Melbourne was recently established to support collaboration in the area of pathogen genomics to promote opportunities for research, capacity building and training, enhancing preparedness and response to infectious diseases.

The Centre’s research strengths span across four key themes:

  • Infectious diseases surveillance and response
  • Antimicrobial Resistance (AMR)
  • One Health
  • Pandemic preparedness and response
  • Infectious diseases surveillance and response

    Infectious diseases surveillance and response

    globe icon

    The COVID-19 pandemic has demonstrated the power of genomics-informed surveillance to enhance the public health response to infectious diseases and highlighted the need for all countries to adopt this technology-driven approach to better prepare and respond to emerging and endemic infectious diseases and to public health globally.

  • Antimicrobial resistance (AMR)

    Antimicrobial resistance (AMR)

    AMR icon

    Antimicrobial resistance (AMR), the ability of microorganisms to resist being killed by medicines such as antibiotics, poses a major and rapidly growing threat to the prevention and treatment of infectious diseases and to public health globally.

  • One Health

    One Health

    one health icon

    One Health is a collaborative, cross-sectoral and multidisciplinary approach that recognises that human health is closely linked to the health of animals and our shared environment.

  • Pandemic preparedness and response

    Pandemic preparedness and response

    mask wearing icon

    Building capacity to rapidly respond to the complex scientific, community and government needs posed by persistent or emerging infectious disease threats. The Centre will achieve this by (i) building on existing surveillance systems to monitor, (ii) detecting and responding to epidemiologic trends, including outbreak investigations, (iii) developing novel diagnostics to support clinical practice and public health, (iv) supporting the development of evidence-based clinical practice and policymaking, (v) informing models of care and surge capacity for health service responses; developing internal mechanisms which link strengths in discovery science to pandemic preparedness.